Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycine for Childhood Onset Psychotic Disorders
NCT00005658Phase 2Completed
- Sponsor
- National Institute of Mental Health
- Start
- May 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glycine in schizophrenia, schizoaffective disorder, psychotic disorder, sponsored by National Institute of Mental Health. Started May 2000; status: completed.
02
Drugs
glycine
03
Conditions
schizophreniaschizoaffective disorderpsychotic disorder
Beyond the preview
Go deeper on NCT00005658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005658.